Causal Association Between Tea Consumption and Bone Health: A Mendelian Randomization Study

Background: Much observational research reported that tea consumption decreases the risk of osteoarthritis (OA), rheumatoid arthritis (RA), and osteoporosis (OP) which are the three major bone disorders. However, the observed correlation is inconclusive. To determine the causal relationship between genetically predicted tea intake and OA, RA, and OP, we performed a two-sample Mendelian randomization (MR) study based on large samples.

Methods: The European population’s genome-wide association meta-analysis (GWAS) dataset identified SNPs associated with tea consumption was obtained from Neale Lab’s analysis of UK Biobank data that comprised 349,376 participants of European ancestry. We extracted genetic data for knee OA (17,885 controls and 4,462 cases), hip OA (50,898 controls and 12,625 cases), and RA (43,923 controls and 14,361 cases) from the UK Biobank and OP cases (93083 controls and 1,175 cases) from FinnGen Data Freeze 2. A MR study was conducted to examine the effect of selected single nucleotide polymorphisms (SNPs) and OA, RA, and OP risk. Several sensitivity analyses were performed with weighted median and inverse-variance weighted methods for estimating the causal effects.

Results: In this MR study, the genetically predicted per one cup increase of tea consumption was not associated with knee OA (OR 1.11,95% CI: 0.79–1.55) using IVW with random effect. Genetic predisposition to tea consumption was not associated with hip OA (OR: 1.20, 95% CI: 0.84–1.71), RA (OR: 1.24 95% CI: 0.81–1.91), and OP (OR: 1.11, 95% CI: 0.89, 1.39). Following the sensitivity analysis, there was no potential pleiotropy.

Conclusion: According to our study, According to our study, there was no statistical power to confirm a causal relationship between tea consumption and the risk of knee OA, hip OA, RA, and OP.

Introduction

Chronic diseases and economic burdens increase as the population ages (1). Osteoarthritis (OA), Rheumatoid Arthritis (RA), osteoporosis (OP) are the three major bone disorders that can cause persistent chronic pain in the elderly (2). The disorder negatively impacts patients’ quality of life due to pain, depression, functional and social disabilities, and it can even impose social costs in severe cases (3–5). Research has explored many factors associated with these bone disorders, such as body mass index (BMI), coffee consumption, tea intake, etc (3, 4).

After water, tea is the most popular drink globally. Like the Mediterranean diet, all kinds of tea are rich in polyphenols, antioxidants that may reduce the risk of inflammatory diseases such as RA (6). As the world’s second most consumed beverage, tea contains flavonoids that may contribute to bone health. Studies show that habitual consumption of tea is positively associated with higher BMD at multiple skeleton sites (7). The use of green tea polyphenols may be beneficial to OA as a therapeutic addition by controlling IL-1β activity (8). There is evidence that tea consumption may benefit RA patients, suggesting that tea consumption could reduce disease activity (9). Green tea possesses powerful antioxidant and anti-inflammatory properties, which can counteract the harmful effects of OP, induced imbalances between osteoblastogenesis and osteoclastogenesis (10).

However, tea contains a lot of caffeine. There are many Mendelian randomization (MR) studies on the relationship between coffee and various types of arthritis. Habitual coffee consumption increases the incidence of OA (11), but not all joints. The effects of coffee were more prominent in knee OA, but not in the hip joint (12). Another Mendelian study found no causal effect of coffee consumption on the incidence of RA (13). Caffeine in tea release amount varies depending on the type of tea and the brewing method. Following 1 min of brewing in 194–203°F (90–95°C) water, a mug of Tazo Earl Gray contains 40 mg of caffeine (14). The caffeine in tea also contributes to the development of mechanical stress-induced OA, suggesting that tea could be a risk factor that promotes OA. Furthermore, Hashempur et al. found a positive relationship between incident RA and caffeinated tea consumption (15). For OP, A study of pre and perimenopausal women (50–60 years of age) in the United States found an inverse relationship between tea consumption and bone mineral density (16).

Since most studies on tea consumption and risk of OP, OA, and RA are observational or experimental, we are unsure whether the confounding factors or reverse causality attribute to the observed associations.

Mendelian randomization is a genetic epidemiological method, which uses genetic variants as instrumental variables. Reverse causation and potential confounding factors can be eliminated by MR (17). Single nucleotide polymorphism (SNPs) are assigned randomly at conception, avoiding residual confounding (18). The causal association between tea consumption with OA, RA, and OP has not been studied using MR. Therefore, we conducted a two-sample MR study to determine the causation.

Materials and Methods

Genetic Instrument Selection

According to Neale Lab genome-wide association meta-analysis (GWAS round 2),¹ the GWAS summary statistics for tea intake (phenotype code: 1488_raw) were based on 349,376 samples of European ancestry from UK Biobank. This GWAS adjusted for age, sex, age 2, sex × age 2, sex × age, and the top twenty principal components. Habitual tea intake was retrieved based on the item: “How many cups of tea do you drink each day?” All instrumental variables were associated with the exposure (e.g., tea consumption) at a genome-wide significance level (P < 5 × 10^–8) with linkage disequilibrium (LD) r² < 0.01 at a 10,000 kb window, which confirmed the independence for the selected genetic variants. In this MR study, 22 independent SNPs with moderate LD were selected as genetic instruments for habitual tea consumption. Detailed information on the relationship between the selected SNPs and exposures is shown in Table 1.

TABLE 1

Table 1. Characteristics of SNPs for habitual tea consumption from the GWAS.

Genetic Summary Data of Osteoarthritis, Rheumatoid Arthritis, and Osteoporosis

The primary outcome in this study was the clinically diagnosed knee OA, hip OA, RA, and OP. The Summary data was available from a wide-ranging meta-analysis of transethnic GWAS. Over 100,000 participants of European and Asian descent participated in the survey. To reduce population stratification bias, we only analyzed data for European, including knee OA (17,885 controls and 4462 cases), hip OA (50,898 controls and 12,625 cases), and RA (43,923 controls and 14,361 cases) from the large GWAS. The secondary outcomes were specifically diagnosed OP. Data of OP was taken from the FinnGen Data Freeze 2.² On January 14, 2020, FinnGen Data Freeze 2 was released to the public. It includes 96,499 individuals, 16 M variants, and 1,122 endpoints. The dataset contains 4,477 OP cases (93083 controls and 1175 cases). Study protocols related to these data have been released and described in the previous studies (19–21). All outcome summary GWAS data in this study were derived from ‘‘ieu open gwas project.³ “The GWAS IDs for the outcomes are as follows: ebi-a-GCST005813 for Knee OA, ebi-a-GCST005810 for hip OA, ieu-a-832 for RA, finn-b-M13_OSTEOPOROSIS for OP. The relevant ethics committees approved all studies that contributed data to these analyses, and all participants provided written informed consent.

Statistical Analysis

This was a two-sample MR analysis. MR, using genetic variants as instrumental variables, is a genetic epidemiologic method that can avoid potential confounding factors and reverse causation. It is assumed that the instrumental variables are valid if it meet all of the following criteria: (1) strongly associated with tea consumption, (2) not associated with confounding factors, and (3) risk association with knee OA, hip OA, RA, and OP were only detected via tea consumption (22, 23) (Figure 1). We tested for weak instrumental variables using F statistics. The F statistic equals [(n-k-1)/k) × R^2/(1-R^2)], where R² represents the variance in tea consumption explained by the genetic instrument, K represents the number of genetic variations, and N represents the sample size. The R² was calculated as follows: 2 × beta² × EAF × (1-EAF)/2 × beta² × EAF × (1-EAF) + se2 × 2 × N × EAF(1-EAF). EAF represents effect allele frequency (24). When F > 10, it is unlikely that a weak instrument will bias the MR estimates. Nevertheless, there may be pleiotropic genetic variants introduced, thus invalidating the IV.

FIGURE 1

Figure 1. Principles of mendelian randomization study. SNPs, single nucleotide polymorphisms.

The Cochran Q-test was applied to check SNPs’ statistical heterogeneity using MR-Egger estimates, with P < 0.05 deemed significantly heterogeneous. Therefore, the IVW method based on random effects was adopted. Several approaches were used to test whether the second and third MR assumptions were violated, including the MR-Egger regression (25), the weighted median (26) and mode (27) methods, an outlier test (MR-PRESSO) (28). MR-Egger is a weighted regression approach that introduces an intercept to accommodate pleiotropy. There was horizontal pleiotropy when the intercept term was away from zero (25). Using this approach, unbiased estimates are achieved in the presence of pleiotropic instruments with the assumption that the magnitude of pleiotropic effects cannot be predicted by the size of the instrumental variables—SNPs related to tea consumption (25).

In addition, funnel plots were used to assess pleiotropy. If the funnel plot is symmetric, there is no potential directional pleiotropy (29). We performed a “leave-one-out” analysis by excluding each SNP in turn. Therefore, individual SNP could be assessed for their influence on causal associations. The PhenoScanner database (version 2.0) was examined for each SNP (30) to determine whether existing risk factors have previously been associated with any significant associations (P < 5 × 10^–8): BMI (31, 32), previous knee injury (32), gout (33), coffee intake (12) for knee OA; Hip dysplasia (34), Steroids use (35), coffee intake (11) for hip OA; hypertension (33), diabetes, smoking (36) for RA; Vitamin D intake, Steroids use, smoking for OP (37). To rule out potential pleiotropic effects, we evaluated the effect of removing these SNPs from the MR estimations.

All analyses were conducted using the “TwoSampleMR,” “MRPRESSO” R packages in RStudio version 3.6.3. The Bonferroni adjustment was used to correct for multiple comparisons (P-value: 0.05/4 outcomes = 0.0125). We computed two-side P-values, with P < 0.0125 regarded as statistically significant.

Results

Mendelian Randomization Study Design

All 22 SNPs together as the instrument together have an F-statistic more than 10 meeting the first assumption for MR study (Table 1). The PhenoScanner database showed one SNPs (rs10741694) associated with RA confounding factors (hypertension, diabetes, smoking), four other SNPs (rs11022751; rs1481012; rs2472297; rs4410790) related to the confounding factors (BMI; previous knee injury; coffee intake) of the knee OA, two other SNPs (rs2472297; rs4410790) related to the confounding factors (coffee intake) of the hip OA. In order to satisfy assumption 2, these SNPs will be eliminated when the corresponding analysis is performed. We used a range of sensitivity analyses to satisfy assumption 3.

Causal Associations Between Tea Consumption and the Risk of Knee Osteoarthritis

We found four SNPs (rs11022751; rs1481012; rs2472297; rs4410790) related to the confounding factors (BMI; previous knee injury; coffee intake) of the knee OA through the PhenoScanner database (Supplementary Table 1). Weeding out the four SNPs, There was no evidence for the causal association between genetically predicted tea intake and knee OA. The OR was 1.11 (95% CI: 0.79–1.55), using IVW with random effect in MR (Figure 2). The weighted Median methods (OR: 1.18, 95% CI: 0.81,1.74) did not support a causal relationship between tea consumption and the risk of knee OA. The estimates for each SNP and scatter plot for two analyses on knee OA were shown in Supplementary Figures 1, 2.

FIGURE 2

Figure 2. Forest plot of MR study using genetic instruments with knee OA excluding four SNPs (rs11022751; rs1481012; rs2472297; rs4410790); OR, odds ratio; IVW, inverse variance weighted; CI, confidence interval; MR, mendelian randomization; OA, osteoarthritis.

In MR-Egger regression, the intercept term indicated that horizontal pleiotropy was unlikely to affect the result (Egger intercept: 0.01, P-value: 0.77). Additionally, As the funnel plot was visually symmetrical, this indicated that pleiotropy had not been established. SNPs did show slight heterogeneity according to Cochran’s Q-test [Q-value (df) = 25.08 (13), P = 0.03 for MR Egger method; Q-value (df) = 25.25 (15), P = 0.05 for IVW method]. “Leave-one-out” analysis demonstrated that overall risk estimates were not significantly affected by any single SNP (Supplementary Figure 3).

Causal Associations Between Tea Consumption and Hip Osteoarthritis

After excluding 2 SNPs (rs2472297; rs4410790) associated with coffee consumption, Based on IVW analyses, no causal relationship was found between tea consumption and hip OA (OR: 1.20, 95% CI: 0.84–1.71) (Figure 3). In MR-Egger regression, the intercept term indicated no horizontal pleiotropy affecting the result (Egger intercept: −0.07, P-value: 0.08). As for genetics instruments, Cochran’s Q statistic suggested no heterogeneity: Q-value (df) = 16.31 (16), P = 0.43 for MR Egger method; Q-value (df) = 19.82 (17), P = 0.28 for IVW method. The forest and scatter plots can be seen in Supplementary Figures 4, 5 and the leave-one-out plot in Supplementary Figure 6.

FIGURE 3

Figure 3. Forest plot of MR study using genetic instruments with hip OA excluding two SNPs (rs2472297; rs4410790). OR, odds ratio; IVW, inverse variance weighted; CI, confidence interval; MR, mendelian randomization; OA, osteoarthritis.

Causal Associations Between Tea Consumption and Rheumatoid Arthritis

The PhenoScanner database showed 2 SNPs (rs10741694; rs397074) associated with RA confounding factors. Excluding the two SNPs. Based on genetic instruments using IVW with random effect analyses, there was no causal link between genetically predicted tea consumption and RA (OR: 1.24 95% CI: 0.81–1.91) (Figure 4). The forest plots can be seen in Supplementary Figure 7. The scatter plot for the two analyses was attached as Supplementary Figure 8 and the leave-one-out plot in Supplementary Figure 9.

FIGURE 4

Figure 4. The plot of the MR study uses genetic instruments with RA excluding two SNPs (rs10741694); OR, odds ratio; IVW, inverse variance weighted; CI, confidence interval; MR, mendelian randomization; RA, rheumatoid arthritis.

As for genetics instruments, Cochran’s Q statistic suggested slight heterogeneity: Q-value (df) = 20.72 (12), P = 0.05 for MR Egger method. Additionally, the intercept of the MR-Egger regression showed no signs of pleiotropy (Egger intercept: 0.05, P-value: 0.09).

Causal Associations Between Tea Consumption and Osteoporosis

The risk of OP did not increase with higher levels of tea consumption due to genetic predisposition. The causal ORs for each cup increased in tea consumption were 1.11 (95% CI: 0.89,1.39) in the IVW estimates. At the same time, MR-Egger and Weighted median methods also confirm no causal relationship between tea consumption and OP, and the P-value were 0.24 and 0.11, respectively (Figure 5). No heterogeneity found in Cochran’s Q statistic [Q-value (df) = 17.47 (15), P = 0.29 for MR Egger method; Q-value (df) = 18.38 (16), P = 0.30 for IVW method]. Detailed forest and scatter plots were shown in Supplementary Figures 10, 11. The leave-one-out analysis shows that none of the single SNP substantially affects the overall risk estimation (Supplementary Figure 12).

FIGURE 5

Figure 5. Forest plot of MR study using genetic instruments with OP. OR, odds ratio; IVW, inverse variance weighted; CI, confidence interval; MR, mendelian randomization; OP, osteoporosis.

Discussion

As far as we know, This is the first MR study to assess the causation of habitual tea intake with risk of knee OA, hip OA, RA, and OP. Our analysis showed that habitual tea consumption does not contributed to knee OA, hip OA, RA, and OP. There is no sign of reverse causality, selection bias, or weak instruments in this MR study.

The association between tea consumption and risk of knee OA, RA, hip OA, and OP is inconsistent in previous observational studies. According to the study of Katiyar et al., IL-1β plays an important role in inflammatory processes that cause OA and other inflammatory diseases; green tea polyphenols were effective in reducing IL-1β-induced inflammatory cytokines preventing the development of OA (8). The results of the cross-sectional study reported by Jin et al. indicated that higher tea consumption (>750 mL/day) was associated with lower RA disease activity compared with non-tea drinkers (9). Kang et al. drew a meta-analysis including 2 prospective cohort studies, 4 case-control studies, 11 cross-sectional studies (38). They found that the OR of OP for the highest vs. the lowest tea consumption types was 0.62 (38). The subgroup analysis indicated tea consumption reduced OP risk (38). In a study in Iran, bone mineral density at the lumbar spine and hip were measured, and it was found that habitual tea consumption was associated with better bone health in women but not in men (35).

However, a prospective cohort study of The Health Initiative Observational Study discovered that women who drank four or more cups of tea per day had an HR of 1.78 (95% CI, 0.83–3.82) for developing RA compared to those without drinking (15). Researchers from the nationwide Women’s Health Study found that habitual tea drinking had little effect on bone density and did not significantly alter fracture risk among United States postmenopausal women (n = 91,465) (16). For the causal relationship between tea intake and OA, RA, and OP, the conclusions of the observational studies were inconsistent, so we designed this MR study.

Several biological mechanisms could underlie the reverse relationship between tea intake and knee OA and RA risk. Firstly, in rat animal models. The tea significantly impacts articular cartilage as well as hyaline cartilage in the growth plate (39). The integrity of fetal articular cartilage may be affected by caffeine exposure in some pregnant women. The caffeine in tea may also increase mechanical stress-induced OA, suggesting that caffeine may be a factor in OA development (40). Secondly, some basic cell lever research reported that Tea contains caffeine and fluoride, which inhibit collagen production, mineralization, osteocalcin levels, and chick osteoblasts which are essential ingredients in bone development (41). Finally, some molecular studies reported that mesenchymal stromal cells treated with caffeine in tea derived from rat bone marrow also showed a similar decrease in ALP expression, RUNX2, and collagen 1 expression, which is very important in cartilage development. In this study, we found that some of the tea-related SNPs (rs2472297; rs4410790) were associated with coffee intake, and to satisfy assumption 2, we excluded these SNPs.

Compared to retrospective analysis and case-control study, the MR method can reduce bias due to individuals. Especially, recall bias was a certainty in an observational study, and the frequency and amount of tea consumption were often inexact in a survey. Additionally, data collection and analysis can be very costly. The MR method reduces this issue to an extent, and sensitivity analyses can be improved by sequentially applying various algorithms.

The two-sample MR design is the greatest strength of our study; Firstly, this study had a large sample size with Summarizing genetic data, which could overcome limitations of conventional epidemiological study designs, such as confounding and reverse causality. It is more time-efficient and less expensive than RCT. Secondly, the MR-PRSSO method was used to identify outliers and demonstrate pleiotropy. Thirdly, we used the “leave-one-out” method as sensitivity analyses increasing the robustness of conclusions.

There were some limitations in this study. First, to minimize the possible impact of stratified populations, the samples of European ancestry were limited. Hence, we could not generalize our results to other ethnicities. Second, the brewing method and type of tea were unclear because there was no specific information about them. The effects of tea type and brewing methods were not assessed. Finally, The data used in this study are summary statistics data, so there is no individual information, and it is impossible to accurately calculate the sample overlap between exposure and outcome.

Conclusion

According to our study, there was no statistical power to confirm a causal relationship between tea consumption and the risk of knee OA, hip OA, RA, and OP.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Author Contributions

SoC and YC participated in study design. SoC, DH, and YP acquired and analyzed the data. ShC participated in the study’s supervision. SoC drafted the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the Science and Technology Plan Project of Fuzhou Science and Technology Bureau in 2019 (No. 2019-SZ-10), Fujian Provincial Clinical Medical Research Center for First Aid and Rehabilitation in Orthopedic Trauma (2020Y2014), and Fuzhou Trauma Medical Center Project (2018080303).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2022.872451/full#supplementary-material

Footnotes

1. ^ http://www.nealelab.is/uk-biobank
2. ^ https://www.finngen.fi
3. ^ https://gwas.mrcieu.ac.uk/

References

1. Hillen JB, Vitry A, Caughey GE. Disease burden, comorbidity and geriatric syndromes in the australian aged care population. Australas J Ageing. (2017) 36:E14–9. doi: 10.1111/ajag.12411

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Hashempur MH, Sadrneshin S, Mosavat SH, Ashraf A. Green tea (camellia sinensis) for patients with knee osteoarthritis: a randomized open-label active-controlled clinical trial. Clin Nutr. (2018) 37:85–90. doi: 10.1016/j.clnu.2016.12.004

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Kinge JM, Knudsen AK, Skirbekk V, Vollset SE. Musculoskeletal disorders in Norway: prevalence of chronicity and use of primary and specialist health care services. BMC Musculoskelet Disord. (2015) 16:75. doi: 10.1186/s12891-015-0536-z

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Majjad A, Errahali Y, Toufik H, Djossou H, Ghassem MA, Kasouati J, et al. Musculoskeletal disorders in patients with diabetes mellitus: a cross-sectional study. Int J Rheumatol. (2018) 2018:3839872. doi: 10.1155/2018/3839872

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Lee YH, Bae S-C, Song GG. Coffee or tea consumption and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol. (2014) 33:1575–83. doi: 10.1007/s10067-014-2631-1

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Westerlind H, Palmqvist I, Saevarsdottir S, Alfredsson L, Klareskog L, Di Giuseppe D. Is tea consumption associated with reduction of risk of rheumatoid arthritis? a swedish case-control study. Arthritis Res Ther. (2021) 23:209. doi: 10.1186/s13075-021-02583-y

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Nash LA, Ward WE. Tea and bone health: findings from human studies, potential mechanisms, and identification of knowledge gaps. Crit Rev Food Sci Nutr. (2015) 57:1603–17. doi: 10.1080/10408398.2014.1001019

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Katiyar SK, Raman C. Green tea: a new option for the prevention or control of osteoarthritis. Arthritis Res Ther. (2011) 13:121. doi: 10.1186/ar3428

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Jin J, Li J, Gan Y, Liu J, Zhao X, Chen J, et al. Tea consumption is associated with decreased disease activity of rheumatoid arthritis in a real-world, large-scale study. Ann Nutr Metab. (2020) 76:54–61. doi: 10.1159/000505952

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Chisari E, Shivappa N, Vyas S. Polyphenol-Rich Foods and Osteoporosis. Curr Pharm Des. (2019) 25:2459–66. doi: 10.2174/1381612825666190722093959

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Nicolopoulos K, Mulugeta A, Zhou A, Hyppönen E. Association between habitual coffee consumption and multiple disease outcomes: a mendelian randomisation phenome-wide association study in the UK biobank. Clin Nutr Edinb Scotl. (2020) 39:3467–76. doi: 10.1016/j.clnu.2020.03.009

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Zhang Y, Fan J, Chen L, Xiong Y, Wu T, Shen S, et al. Causal association of coffee consumption and total, knee, hip and self-reported osteoarthritis: a mendelian randomization study. Front Endocrinol. (2021) 12:768529. doi: 10.3389/fendo.2021.768529

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Bae S-C, Lee YH. Coffee consumption and the risk of rheumatoid arthritis and systemic lupus erythematosus: a mendelian randomization Study. Clin Rheumatol. (2018) 37:2875–9. doi: 10.1007/s10067-018-4278-9

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Chin JM, Merves ML, Goldberger BA, Sampson-Cone A, Cone EJ. Caffeine content of brewed teas. J Anal Toxicol. (2008) 32:702–4. doi: 10.1093/jat/32.8.702

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Lamichhane D, Collins C, Constantinescu F, Walitt B, Pettinger M, Parks C, et al. Coffee and tea consumption in relation to risk of rheumatoid arthritis in the women’s health initiative observational cohort. J Clin Rheumatol. (2019) 25:127–32. doi: 10.1097/rhu.0000000000000788

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Chen Z. Habitual tea consumption and risk of osteoporosis: a prospective study in the women’s health initiative observational cohort. Am J Epidemiol. (2003) 158:772–81. doi: 10.1093/aje/kwg214

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. (2008) 27:1133–63. doi: 10.1002/sim.3034

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Larsson SC. Mendelian randomization as a tool for causal inference in human nutrition and metabolism. Curr Opin Lipidol. (2021) 32:1–8. doi: 10.1097/MOL.0000000000000721

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Wu JHY, Lemaitre RN, Manichaikul A, Guan W, Tanaka T, Foy M, et al. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ Cardiovasc Genet. (2013) 6:171–83. doi: 10.1161/CIRCGENETICS.112.964619

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. (2014) 506:376–81. doi: 10.1038/nature12873

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Zengini E, Hatzikotoulas K, Tachmazidou I, Steinberg J, Hartwig FP, Southam L, et al. Genome-wide analyses using UK biobank data provide insights into the genetic architecture of osteoarthritis. Nat Genet. (2018) 50:549–58. doi: 10.1038/s41588-018-0079-y

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. (2007) 16:309–30. doi: 10.1177/0962280206077743

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. (2018) 47:358. doi: 10.1093/ije/dyx275

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants. Int J Epidemiol. (2011) 40:740–52. doi: 10.1093/ije/dyq151

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int J Epidemiol. (2015) 44:512–25. doi: 10.1093/ije/dyv080

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. (2016) 40:304–14. doi: 10.1002/gepi.21965

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. (2017) 46:1985–98. doi: 10.1093/ije/dyx102

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. (2018) 50:693–8. doi: 10.1038/s41588-018-0099-7

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiol Camb Mass. (2017) 28:30–42. doi: 10.1097/EDE.0000000000000559

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinforma Oxf Engl. (2019) 35:4851–3. doi: 10.1093/bioinformatics/btz469

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Takiguchi R, Komatsu R, Kitamura K, Watanabe Y, Takahashi A, Kobayashi R, et al. Modifiable factors associated with symptomatic knee osteoarthritis: the murakami cohort study. Maturitas. (2019) 128:53–9. doi: 10.1016/j.maturitas.2019.06.013

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Kulkarni K, Karssiens T, Kumar V, Pandit H. Obesity and osteoarthritis. Maturitas. (2016) 89:22–8. doi: 10.1016/j.maturitas.2016.04.006

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, et al. Hypertension in rheumatoid arthritis. Rheumatol Oxf Engl. (2008) 47:1286–98. doi: 10.1093/rheumatology/ken159

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Morvan J, Bouttier R, Mazieres B, Verrouil E, Pouchot J, Rat A-C, et al. Relationship between hip dysplasia, pain, and osteoarthritis in a cohort of patients with hip symptoms. J Rheumatol. (2013) 40:1583–9. doi: 10.3899/jrheum.121544

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Yan Y-S, Qu Z, Yu D-Q, Wang W, Yan S, Huang H-F. Sex steroids and osteoarthritis: a mendelian randomization study. Front Endocrinol. (2021) 12:683226. doi: 10.3389/fendo.2021.683226

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One. (2015) 10:e0117952. doi: 10.1371/journal.pone.0117952

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Picado C, Luengo M. Corticosteroid-induced bone loss. prevention and management. Drug Saf. (1996) 15:347–59. doi: 10.2165/00002018-199615050-00005

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Sun K, Wang L, Ma Q, Cui Q, Lv Q, Zhang W, et al. Association between tea consumption and osteoporosis. Medicine. (2017) 96:9034. doi: 10.1097/md.0000000000009034

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Reis AMS, Oliveira KP, de Paula IHF, da Silva AP, Tarragô JF, de Melo Ocarino N, et al. Nonlinear effects of caffeine on the viability, synthesis and gene expression of chondrocytes from the offspring of rats treated during pregnancy. Acta Histochem. (2018) 120:505–12. doi: 10.1016/j.acthis.2018.06.001

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Guillán-Fresco M, Franco-Trepat E, Alonso-Pérez A, Jorge-Mora A, López-Fagúndez M, Pazos-Pérez A, et al. Caffeine, a risk factor for osteoarthritis and longitudinal bone growth inhibition. J Clin Med. (2020) 9:jcm9041163. doi: 10.3390/jcm9041163

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Tassinari MS, Gerstenfeld LC, Stein GS, Lian JB. Effect of caffeine on parameters of osteoblast growth and differentiation of a mineralized extracellular matrix in vitro. J Bone Miner Res Off J Am Soc Bone Miner Res. (1991) 6:1029–36. doi: 10.1002/jbmr.5650061003

PubMed Abstract | CrossRef Full Text | Google Scholar